No products in the cart.
![2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]](data:image/svg+xml;base64,PHN2ZyB2aWV3Qm94PSIwIDAgMSAxIiB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==)
Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy
1. A new AI workflow utilizing large language models can predict with 99% accuracy which ulcerative colitis patients will remain...
AI Roundup
Artificial intelligence designed drugs Hit 90% Phase I success rate in trials
1. AI-native biotechnology firms are reporting Phase I success rates between 80% and 90%, nearly doubling the historical industry average...
FDA clears Medtronic stealth AXiS AI-Robotic spine system
1. The Stealth AXiS™ system has received regulatory clearance as the first platform to natively unify AI-driven planning and robotic...
2MM: AI Roundup- Medtronic’s AI-Robotic Spine Platform, 90% Phase I Success for AI-Designed Drugs, and UCSD’s AI Cancer Risk Predictor [Feb 17th, 2026]
Medtronic Stealth AXiS system integrates AI-robotics for spine care The FDA recently issued a landmark clearance for a surgical platform...
Illumina’s billion cell atlas tries to solve artificial intelligence’s data bottleneck in biology
1. Illumina’s Billion Cell Atlas aims to standardize massive CRISPR perturbation data to make biological response patterns more learnable for...
Anthropic positions Claude as workflow software for regulated healthcare, not a chatbot
1. Anthropic is packaging Claude as a governed healthcare workflow tool aimed at documentation, prior authorization, and other high friction...
AstraZeneca moves to own multimodal oncology AI with Modella
1. AstraZeneca is acquiring Modella AI to embed multimodal foundation models into oncology R&D and strengthen biomarker driven trial strategy....
NVIDIA and Lilly put $1B behind AI as core drug infrastructure
1. NVIDIA and Eli Lilly plan to invest up to $1B over five years in a joint AI lab to...
2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]
NVIDIA and Lilly put $1B behind AI as core drug infrastructure During the JPMorgan Healthcare Conference week in mid January...
Lilly unveils TuneLab AI platform for biotechs
1. Lilly launched TuneLab on September 9, 2025, giving biotechs access to AI models trained on more than $1 billion...
